Results 171 to 180 of about 2,729,470 (315)
Strengthening health technology assessment (HTA) in the European Union: insights from Slovenia's implementation journey. [PDF]
Beravs-Bervar K +6 more
europepmc +1 more source
Objective Despite well‐described biologic causes, the public views unhealthy lifestyle choices as the primary cause of gout. This study investigated how causal beliefs about gout influence the public's views about its management. Methods In a randomized study, 201 members of the public viewed one of two 2‐minute videos about gout.
Rachel Murdoch +6 more
wiley +1 more source
Mapping the regulatory landscape for environmental sustainability of medical device practices within the European Union. [PDF]
Zarro M +4 more
europepmc +1 more source
Objective The study aimed to identify symptom‐based predictors of dry eye disease (DED) signs in the Sjögren's International Collaborative Clinical Alliance (SICCA) cohort. Methods We performed a retrospective analysis examining 16 ocular symptoms (most graded 0–4) and artificial tear (AT) use (graded 0–3) as predictors of DED signs (abnormal ocular ...
Pragnya R. Donthineni +7 more
wiley +1 more source
Workforce planning, staffing and education requirements for radiation therapists (RTTs) in the European Union as part of the EU-REST project. [PDF]
Coffey M +2 more
europepmc +1 more source
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel +6 more
wiley +1 more source
Artificial Intelligence-Based Medical Devices for Diabetic Retinopathy Screening in the European Union. [PDF]
Grzybowski A, Jin K.
europepmc +1 more source
Objective The concern that nonsteroidal anti‐inflammatory drugs (NSAIDs) may precipitate flares of inflammatory bowel disease (IBD) has limited their use in managing musculoskeletal symptoms in those with IBD, but safety data are mixed. Methods This retrospective cohort study included patients with IBD aged at least 18 years from Optum's deidentified ...
Adam S. Mayer +4 more
wiley +1 more source
Evaluation of the EU framework for national Roma integration strategies [PDF]
Bartlett, William +3 more
core +1 more source

